世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
乱用薬物（DOA）検査-世界市場シェアとランキング、全体売上高と需要予測 2024-2030Drug of Abuse (DOA) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 乱用薬物検査は、競合結合の原理に基づく免疫測定法である。 乱用薬物（DOA）検査の世界市場は、2023年には6億3,100万米ドルと推定され、予測期間2024-2030年のCAGRは6.8%で、2030年には9億7,070万米ドルに再調... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー乱用薬物検査は、競合結合の原理に基づく免疫測定法である。乱用薬物（DOA）検査の世界市場は、2023年には6億3,100万米ドルと推定され、予測期間2024-2030年のCAGRは6.8%で、2030年には9億7,070万米ドルに再調整されると予測されている。 2022年の薬物乱用検査市場は、高い研究開発投資、グローバル企業の存在、技術的に高度なソリューションの採用増加、大手企業の努力により、北米が支配的となる。北米では、違法薬物の使用増加とそれに伴う健康問題の増加により、米国が90%を占める主要シェアを占めている。職場における違法薬物消費の監視強化や薬物密売の増加も市場成長の要因である。 レポートの範囲 本レポートは、乱用薬物（DOA）検査の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の乱用薬物（DOA）検査の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 乱用薬物（DOA）検査の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、乱用薬物（DOA）検査に関する十分な情報に基づいたビジネス上の意思決定を行うことを支援します。 市場区分 企業別 シーメンス メルク ロシュ サーモフィッシャーサイエンティフィック バイオ・ラッド アボット クエスト・ダイアグノスティックス サイケメディックス タイプ別セグメント 尿 唾液 毛髪 その他 用途別セグメント 病院 研究所 職場 家庭 その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章：報告書のスコープ、世界の総市場規模を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章 乱用薬物（DOA）検査メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけやすくします。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場におけるブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでの乱用薬物（DOA）検査の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場スペース、市場規模を紹介しています。 第6章 乱用薬物（DOA）検査の国別収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロフィールを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Drug of Abuse (DOA) Testing Product Introduction 1.2 Global Drug of Abuse (DOA) Testing Market Size Forecast 1.3 Drug of Abuse (DOA) Testing Market Trends & Drivers 1.3.1 Drug of Abuse (DOA) Testing Industry Trends 1.3.2 Drug of Abuse (DOA) Testing Market Drivers & Opportunity 1.3.3 Drug of Abuse (DOA) Testing Market Challenges 1.3.4 Drug of Abuse (DOA) Testing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Drug of Abuse (DOA) Testing Players Revenue Ranking (2023) 2.2 Global Drug of Abuse (DOA) Testing Revenue by Company (2019-2024) 2.3 Key Companies Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Drug of Abuse (DOA) Testing Product Offered 2.5 Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing 2.6 Drug of Abuse (DOA) Testing Market Competitive Analysis 2.6.1 Drug of Abuse (DOA) Testing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Drug of Abuse (DOA) Testing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Urine 3.1.2 Saliva 3.1.3 Hair 3.1.4 Others 3.2 Global Drug of Abuse (DOA) Testing Sales Value by Type 3.2.1 Global Drug of Abuse (DOA) Testing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Drug of Abuse (DOA) Testing Sales Value, by Type (2019-2030) 3.2.3 Global Drug of Abuse (DOA) Testing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Laboratories 4.1.3 Workplace 4.1.4 At-Home 4.1.5 Others 4.2 Global Drug of Abuse (DOA) Testing Sales Value by Application 4.2.1 Global Drug of Abuse (DOA) Testing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Drug of Abuse (DOA) Testing Sales Value, by Application (2019-2030) 4.2.3 Global Drug of Abuse (DOA) Testing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Drug of Abuse (DOA) Testing Sales Value by Region 5.1.1 Global Drug of Abuse (DOA) Testing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Drug of Abuse (DOA) Testing Sales Value by Region (2019-2024) 5.1.3 Global Drug of Abuse (DOA) Testing Sales Value by Region (2025-2030) 5.1.4 Global Drug of Abuse (DOA) Testing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.2.2 North America Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.3.2 Europe Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.4.2 Asia Pacific Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.5.2 South America Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.6.2 Middle East & Africa Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Drug of Abuse (DOA) Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Drug of Abuse (DOA) Testing Sales Value 6.3 United States 6.3.1 United States Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.3.2 United States Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.4.2 Europe Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.5.2 China Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.6.2 Japan Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.7.2 South Korea Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.8.2 Southeast Asia Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.9.2 India Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Siemens 7.1.1 Siemens Profile 7.1.2 Siemens Main Business 7.1.3 Siemens Drug of Abuse (DOA) Testing Products, Services and Solutions 7.1.4 Siemens Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.1.5 Siemens Recent Developments 7.2 Merck 7.2.1 Merck Profile 7.2.2 Merck Main Business 7.2.3 Merck Drug of Abuse (DOA) Testing Products, Services and Solutions 7.2.4 Merck Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.2.5 Merck Recent Developments 7.3 Roche 7.3.1 Roche Profile 7.3.2 Roche Main Business 7.3.3 Roche Drug of Abuse (DOA) Testing Products, Services and Solutions 7.3.4 Roche Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.3.5 Thermo Fisher Scientific Recent Developments 7.4 Thermo Fisher Scientific 7.4.1 Thermo Fisher Scientific Profile 7.4.2 Thermo Fisher Scientific Main Business 7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products, Services and Solutions 7.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.4.5 Thermo Fisher Scientific Recent Developments 7.5 Bio-Rad 7.5.1 Bio-Rad Profile 7.5.2 Bio-Rad Main Business 7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Products, Services and Solutions 7.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.5.5 Bio-Rad Recent Developments 7.6 Abbott 7.6.1 Abbott Profile 7.6.2 Abbott Main Business 7.6.3 Abbott Drug of Abuse (DOA) Testing Products, Services and Solutions 7.6.4 Abbott Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.6.5 Abbott Recent Developments 7.7 Quest Diagnostics 7.7.1 Quest Diagnostics Profile 7.7.2 Quest Diagnostics Main Business 7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Products, Services and Solutions 7.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.7.5 Quest Diagnostics Recent Developments 7.8 Psychemedics 7.8.1 Psychemedics Profile 7.8.2 Psychemedics Main Business 7.8.3 Psychemedics Drug of Abuse (DOA) Testing Products, Services and Solutions 7.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.8.5 Psychemedics Recent Developments 8 Industry Chain Analysis 8.1 Drug of Abuse (DOA) Testing Industrial Chain 8.2 Drug of Abuse (DOA) Testing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Drug of Abuse (DOA) Testing Sales Model 8.5.2 Sales Channel 8.5.3 Drug of Abuse (DOA) Testing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe drug of abuse test is an immunoassay based on the principle of competitive binding. Table of Contents1 Market Overview1.1 Drug of Abuse (DOA) Testing Product Introduction 1.2 Global Drug of Abuse (DOA) Testing Market Size Forecast 1.3 Drug of Abuse (DOA) Testing Market Trends & Drivers 1.3.1 Drug of Abuse (DOA) Testing Industry Trends 1.3.2 Drug of Abuse (DOA) Testing Market Drivers & Opportunity 1.3.3 Drug of Abuse (DOA) Testing Market Challenges 1.3.4 Drug of Abuse (DOA) Testing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Drug of Abuse (DOA) Testing Players Revenue Ranking (2023) 2.2 Global Drug of Abuse (DOA) Testing Revenue by Company (2019-2024) 2.3 Key Companies Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Drug of Abuse (DOA) Testing Product Offered 2.5 Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing 2.6 Drug of Abuse (DOA) Testing Market Competitive Analysis 2.6.1 Drug of Abuse (DOA) Testing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Drug of Abuse (DOA) Testing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Urine 3.1.2 Saliva 3.1.3 Hair 3.1.4 Others 3.2 Global Drug of Abuse (DOA) Testing Sales Value by Type 3.2.1 Global Drug of Abuse (DOA) Testing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Drug of Abuse (DOA) Testing Sales Value, by Type (2019-2030) 3.2.3 Global Drug of Abuse (DOA) Testing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Laboratories 4.1.3 Workplace 4.1.4 At-Home 4.1.5 Others 4.2 Global Drug of Abuse (DOA) Testing Sales Value by Application 4.2.1 Global Drug of Abuse (DOA) Testing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Drug of Abuse (DOA) Testing Sales Value, by Application (2019-2030) 4.2.3 Global Drug of Abuse (DOA) Testing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Drug of Abuse (DOA) Testing Sales Value by Region 5.1.1 Global Drug of Abuse (DOA) Testing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Drug of Abuse (DOA) Testing Sales Value by Region (2019-2024) 5.1.3 Global Drug of Abuse (DOA) Testing Sales Value by Region (2025-2030) 5.1.4 Global Drug of Abuse (DOA) Testing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.2.2 North America Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.3.2 Europe Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.4.2 Asia Pacific Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.5.2 South America Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Drug of Abuse (DOA) Testing Sales Value, 2019-2030 5.6.2 Middle East & Africa Drug of Abuse (DOA) Testing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Drug of Abuse (DOA) Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Drug of Abuse (DOA) Testing Sales Value 6.3 United States 6.3.1 United States Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.3.2 United States Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.4.2 Europe Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.5.2 China Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.6.2 Japan Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.7.2 South Korea Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.8.2 Southeast Asia Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Drug of Abuse (DOA) Testing Sales Value, 2019-2030 6.9.2 India Drug of Abuse (DOA) Testing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Drug of Abuse (DOA) Testing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Siemens 7.1.1 Siemens Profile 7.1.2 Siemens Main Business 7.1.3 Siemens Drug of Abuse (DOA) Testing Products, Services and Solutions 7.1.4 Siemens Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.1.5 Siemens Recent Developments 7.2 Merck 7.2.1 Merck Profile 7.2.2 Merck Main Business 7.2.3 Merck Drug of Abuse (DOA) Testing Products, Services and Solutions 7.2.4 Merck Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.2.5 Merck Recent Developments 7.3 Roche 7.3.1 Roche Profile 7.3.2 Roche Main Business 7.3.3 Roche Drug of Abuse (DOA) Testing Products, Services and Solutions 7.3.4 Roche Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.3.5 Thermo Fisher Scientific Recent Developments 7.4 Thermo Fisher Scientific 7.4.1 Thermo Fisher Scientific Profile 7.4.2 Thermo Fisher Scientific Main Business 7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products, Services and Solutions 7.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.4.5 Thermo Fisher Scientific Recent Developments 7.5 Bio-Rad 7.5.1 Bio-Rad Profile 7.5.2 Bio-Rad Main Business 7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Products, Services and Solutions 7.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.5.5 Bio-Rad Recent Developments 7.6 Abbott 7.6.1 Abbott Profile 7.6.2 Abbott Main Business 7.6.3 Abbott Drug of Abuse (DOA) Testing Products, Services and Solutions 7.6.4 Abbott Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.6.5 Abbott Recent Developments 7.7 Quest Diagnostics 7.7.1 Quest Diagnostics Profile 7.7.2 Quest Diagnostics Main Business 7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Products, Services and Solutions 7.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.7.5 Quest Diagnostics Recent Developments 7.8 Psychemedics 7.8.1 Psychemedics Profile 7.8.2 Psychemedics Main Business 7.8.3 Psychemedics Drug of Abuse (DOA) Testing Products, Services and Solutions 7.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2019-2024) 7.8.5 Psychemedics Recent Developments 8 Industry Chain Analysis 8.1 Drug of Abuse (DOA) Testing Industrial Chain 8.2 Drug of Abuse (DOA) Testing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Drug of Abuse (DOA) Testing Sales Model 8.5.2 Sales Channel 8.5.3 Drug of Abuse (DOA) Testing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|